rdf:type |
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0012621,
umls-concept:C0016018,
umls-concept:C0021308,
umls-concept:C0038418,
umls-concept:C0042153,
umls-concept:C0205042,
umls-concept:C0243161,
umls-concept:C0681698,
umls-concept:C0936012,
umls-concept:C1414461,
umls-concept:C1947917,
umls-concept:C2348867
|
pubmed:issue |
3
|
pubmed:dateCreated |
1996-5-22
|
pubmed:abstractText |
This study sought to readdress the definition of uncomplicated myocardial infarction and to apply clinical criteria for early discharge of such patients in the thrombolytic era.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0735-1097
|
pubmed:author |
pubmed-author:CaliffR MRM,
pubmed-author:CoxFF,
pubmed-author:GoreJ MJM,
pubmed-author:GuerciAA,
pubmed-author:HorganJ HJH,
pubmed-author:MaraD DDD,
pubmed-author:NewbyL KLK,
pubmed-author:StebbinsAA,
pubmed-author:TopolE JEJ,
pubmed-author:Van de WerfFF,
pubmed-author:WeaverW DWD
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
625-32
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8606274-Aged,
pubmed-meshheading:8606274-Female,
pubmed-meshheading:8606274-Fibrinolytic Agents,
pubmed-meshheading:8606274-Follow-Up Studies,
pubmed-meshheading:8606274-Humans,
pubmed-meshheading:8606274-Length of Stay,
pubmed-meshheading:8606274-Male,
pubmed-meshheading:8606274-Middle Aged,
pubmed-meshheading:8606274-Myocardial Infarction,
pubmed-meshheading:8606274-Patient Discharge,
pubmed-meshheading:8606274-Patient Selection,
pubmed-meshheading:8606274-Prognosis,
pubmed-meshheading:8606274-Recurrence,
pubmed-meshheading:8606274-Severity of Illness Index,
pubmed-meshheading:8606274-Streptokinase,
pubmed-meshheading:8606274-Tissue Plasminogen Activator
|
pubmed:year |
1996
|
pubmed:articleTitle |
Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial.
|
pubmed:affiliation |
Department of Medicine (Cardiology), Duke University Medical Center, Durham, North Carolina 27710, USA.
|
pubmed:publicationType |
Journal Article
|